Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prazosin for Raynaud's Phenomenon in Progressive Systemic Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437004/0/Tai_chi_for_primary_prevention_of_cardiovascular_disease_New. Accessed 28 March 2024.
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/0/Tai_chi_for_primary_prevention_of_cardiovascular_disease_New. Accessed March 28, 2024.
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/0/Tai_chi_for_primary_prevention_of_cardiovascular_disease_New
Prazosin for Raynaud's Phenomenon in Progressive Systemic Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/0/Tai_chi_for_primary_prevention_of_cardiovascular_disease_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
ID - 437004
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/0/Tai_chi_for_primary_prevention_of_cardiovascular_disease_New
DB - Evidence Central
DP - Unbound Medicine
ER -